Environmental Substances Associated with Chronic Obstructive Pulmonary Disease-A Scoping Review
- PMID: 35409627
- PMCID: PMC8997594
- DOI: 10.3390/ijerph19073945
Environmental Substances Associated with Chronic Obstructive Pulmonary Disease-A Scoping Review
Abstract
Chronic obstructive pulmonary disease (COPD) is a slowly developing non-communicable disease (NCD), causing non-reversible obstruction and leading to marked morbidity and mortality. Besides traditional risk factors such as smoking, some environmental substances can augment the risk of COPD. The European Human Biomonitoring Initiative (HBM4EU) is a program evaluating citizens' exposure to various environmental substances and their possible health impacts. Within the HBM4EU, eighteen priority substances or substance groups were chosen. In this scoping review, seven of these substances or substance groups are reported to have an association or a possible association with COPD. Main exposure routes, vulnerable and high-exposure risk groups, and matrices where these substances are measured are described. Pesticides in general and especially organophosphate and carbamate insecticides, and some herbicides, lead (Pb), and polycyclic aromatic hydrocarbons (PAHs) showed an association, and cadmium (Cd), chromium (Cr and CrVI), arsenic (As), and diisocyanates, a possible association with COPD and/or decreased lung function. Due to long latency in COPD's disease process, the role of chemical exposure as a risk factor for COPD is probably underestimated. More research is needed to support evidence-based conclusions. Generally, chemical exposure is a growing issue of concern, and prompt action is needed to safeguard public health.
Keywords: HBM4EU; arsenic (As); cadmium (Cd); chemical exposure; chromium (Cr); chronic obstructive pulmonary disease (COPD); diisocyanates; human biomonitoring (HBM); lead (Pb); pesticides; polycyclic aromatic hydrocarbons (PAHs).
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- European Respiratory Society (ERS) The Economic Burden of Lung Disease. 2021. [(accessed on 5 August 2021)]. Available online: https://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/
-
- WHO Chronic Obstructive Pulmonary Disease (COPD) [(accessed on 25 December 2020)]. Available online: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...
-
- Soriano J.B., Kendrick P.J., Paulson K.R., Gupta V., Abrams E.M., Adedoyin R.A., Adhikari T.B., Advani S.M., Agrawal A., Ahmadian E., et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. 2020;8:585–596. doi: 10.1016/S2213-2600(20)30105-3. - DOI - PMC - PubMed
-
- Global Initiative for Chronic Obstructive Lung Disease Global Strategy for The Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2021 Report) 2020. [(accessed on 2 February 2021)]. Available online: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25....
-
- National Health Service (NHS) Chronic Obstructive Pulmonary Disease (COPD) 2019. [(accessed on 4 August 2021)]. Available online: https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials